Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Pharmacologica Sinica|April 27, 2018
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeuticsZhuo-Ming Li, Suo-Wen Xu, Pei-Qing Liu
World Journal of Gastroenterology|February 25, 2010
Pathological differential diagnosis of solid-pseudopapillary neoplasm and endocrine tumors of the pancreasBao-An Liu, Zhuo-Ming Li, Zhan-San Su, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 9, 2008
[A comparative research on quality of Vitmin C Yinqiao tablets from different manufacturers]Wei-nan Zhang, Yu Xiang, Yuan-yuan Jiang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|July 28, 2007
[Effect compound decoction on notoginsenosides in Panax notoginseng]Ming-Qing Huang, Zhuo-Ming Li, Xiang-Li Li, et al.
Molecular and Cellular Endocrinology|May 27, 2014
AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophyMin Liu, Zhe Li, Guo-Wen Chen, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 30, 2015
Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathwayXue-Ping Liu, Hui Gao, Xiao-Yang Huang, et al.
Acta Pharmacologica Sinica|September 24, 2020
Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivativesXiao-Lei Zhang, Zhuo-Ming Li, Jian-Tao Ye, et al.
Acta Pharmacologica Sinica|February 28, 2017
Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodelingGuo-Shuai Feng, Cui-Ge Zhu, Zhuo-Ming Li, et al.
Acta Pharmacologica Sinica|July 22, 2018
PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophyQian Li, Zhuo-Ming Li, Shu-Ya Sun, et al.
Acta Pharmacologica Sinica|June 27, 2017
C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signalingPan-Xia Wang, Zhuo-Ming Li, Si-Dong Cai, et al.
Pageof 2